SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.

Severe acute respiratory syndrome coronavirus (SARS-CoV) infection often caused severe end stage lung disease and organizing phase diffuse alveolar damage, especially in the elderly. The virus-host interactions that governed development of these acute end stage lung diseases and death are unknown. T...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthew B Frieman, Jun Chen, Thomas E Morrison, Alan Whitmore, William Funkhouser, Jerrold M Ward, Elaine W Lamirande, Anjeanette Roberts, Mark Heise, Kanta Subbarao, Ralph S Baric
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
Acceso en línea:https://doaj.org/article/d2658d2d3790420ea53e50673aba3cc3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d2658d2d3790420ea53e50673aba3cc3
record_format dspace
spelling oai:doaj.org-article:d2658d2d3790420ea53e50673aba3cc32021-11-25T05:48:10ZSARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.1553-73661553-737410.1371/journal.ppat.1000849https://doaj.org/article/d2658d2d3790420ea53e50673aba3cc32010-04-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20386712/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Severe acute respiratory syndrome coronavirus (SARS-CoV) infection often caused severe end stage lung disease and organizing phase diffuse alveolar damage, especially in the elderly. The virus-host interactions that governed development of these acute end stage lung diseases and death are unknown. To address this question, we evaluated the role of innate immune signaling in protection from human (Urbani) and a recombinant mouse adapted SARS-CoV, designated rMA15. In contrast to most models of viral pathogenesis, infection of type I, type II or type III interferon knockout mice (129 background) with either Urbani or MA15 viruses resulted in clinical disease outcomes, including transient weight loss, denuding bronchiolitis and alveolar inflammation and recovery, identical to that seen in infection of wildtype mice. This suggests that type I, II and III interferon signaling play minor roles in regulating SARS pathogenesis in mouse models. In contrast, infection of STAT1-/- mice resulted in severe disease, high virus titer, extensive pulmonary lesions and 100% mortality by day 9 and 30 post-infection with rMA15 or Urbani viruses, respectively. Non-lethal in BALB/c mice, Urbani SARS-CoV infection in STAT1-/- mice caused disseminated infection involving the liver, spleen and other tissues after day 9. These findings demonstrated that SARS-CoV pathogenesis is regulated by a STAT1 dependent but type I, II and III interferon receptor independent, mechanism. In contrast to a well documented role in innate immunity, we propose that STAT1 also protects mice via its role as an antagonist of unrestrained cell proliferation.Matthew B FriemanJun ChenThomas E MorrisonAlan WhitmoreWilliam FunkhouserJerrold M WardElaine W LamirandeAnjeanette RobertsMark HeiseKanta SubbaraoRalph S BaricPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 6, Iss 4, p e1000849 (2010)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Matthew B Frieman
Jun Chen
Thomas E Morrison
Alan Whitmore
William Funkhouser
Jerrold M Ward
Elaine W Lamirande
Anjeanette Roberts
Mark Heise
Kanta Subbarao
Ralph S Baric
SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
description Severe acute respiratory syndrome coronavirus (SARS-CoV) infection often caused severe end stage lung disease and organizing phase diffuse alveolar damage, especially in the elderly. The virus-host interactions that governed development of these acute end stage lung diseases and death are unknown. To address this question, we evaluated the role of innate immune signaling in protection from human (Urbani) and a recombinant mouse adapted SARS-CoV, designated rMA15. In contrast to most models of viral pathogenesis, infection of type I, type II or type III interferon knockout mice (129 background) with either Urbani or MA15 viruses resulted in clinical disease outcomes, including transient weight loss, denuding bronchiolitis and alveolar inflammation and recovery, identical to that seen in infection of wildtype mice. This suggests that type I, II and III interferon signaling play minor roles in regulating SARS pathogenesis in mouse models. In contrast, infection of STAT1-/- mice resulted in severe disease, high virus titer, extensive pulmonary lesions and 100% mortality by day 9 and 30 post-infection with rMA15 or Urbani viruses, respectively. Non-lethal in BALB/c mice, Urbani SARS-CoV infection in STAT1-/- mice caused disseminated infection involving the liver, spleen and other tissues after day 9. These findings demonstrated that SARS-CoV pathogenesis is regulated by a STAT1 dependent but type I, II and III interferon receptor independent, mechanism. In contrast to a well documented role in innate immunity, we propose that STAT1 also protects mice via its role as an antagonist of unrestrained cell proliferation.
format article
author Matthew B Frieman
Jun Chen
Thomas E Morrison
Alan Whitmore
William Funkhouser
Jerrold M Ward
Elaine W Lamirande
Anjeanette Roberts
Mark Heise
Kanta Subbarao
Ralph S Baric
author_facet Matthew B Frieman
Jun Chen
Thomas E Morrison
Alan Whitmore
William Funkhouser
Jerrold M Ward
Elaine W Lamirande
Anjeanette Roberts
Mark Heise
Kanta Subbarao
Ralph S Baric
author_sort Matthew B Frieman
title SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
title_short SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
title_full SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
title_fullStr SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
title_full_unstemmed SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
title_sort sars-cov pathogenesis is regulated by a stat1 dependent but a type i, ii and iii interferon receptor independent mechanism.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/d2658d2d3790420ea53e50673aba3cc3
work_keys_str_mv AT matthewbfrieman sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT junchen sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT thomasemorrison sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT alanwhitmore sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT williamfunkhouser sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT jerroldmward sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT elainewlamirande sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT anjeanetteroberts sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT markheise sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT kantasubbarao sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
AT ralphsbaric sarscovpathogenesisisregulatedbyastat1dependentbutatypeiiiandiiiinterferonreceptorindependentmechanism
_version_ 1718414487767220224